SMTL ID : 7f83.1

Crystal Structure of a receptor in Complex with inverse agonist

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.94 Å

Oligo State

homo-dimer

Ligands

6 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)

OLC.1: 7 residues within 4Å: Chain A: V.22, N.392, R.399 Chain B: V.17, M.62, L.66 Ligands: OLC.7 3 PLIP interactions: 1 interactions with chain A, 2 interactions with chain B Hydrogen bonds: A:N.392 Hydrophobic interactions: B:V.17, B:L.66 OLC.2: 5 residues within 4Å: Chain A: L.194, A.334, F.338, L.345, V.349 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:F.338, A:F.338, A:L.345, A:V.349 OLC.4: 9 residues within 4Å: Chain A: A.25, L.29, L.32, R.36, L.405 Chain B: W.75, N.76, F.77 Ligands: OLC.5 6 PLIP interactions: 5 interactions with chain A, 1 interactions with chain B Hydrophobic interactions: A:A.25, A:L.29, A:L.32, A:L.405 Salt bridges: A:R.36 Hydrogen bonds: B:N.76 OLC.5: 4 residues within 4Å: Chain B: L.60, F.77, F.85 Ligands: OLC.4 1 PLIP interactions: 1 interactions with chain B Hydrophobic interactions: B:F.85 OLC.6: 3 residues within 4Å: Chain B: V.17, A.18, W.70 2 PLIP interactions: 2 interactions with chain B Hydrophobic interactions: B:V.17, B:A.18 OLC.7: 13 residues within 4Å: Chain A: V.21, A.25, G.26, I.389, F.403, F.408 Chain B: T.13, P.63, L.66, V.67, W.70, Y.72 Ligands: OLC.1 8 PLIP interactions: 4 interactions with chain B, 4 interactions with chain A Hydrophobic interactions: B:T.13, B:L.66, B:V.67, B:W.70, A:V.21, A:A.25, A:I.389, A:F.408

2 x 1KQ: 2-(2-methylimidazo[2,1-b][1,3]thiazol-6-yl)-1-[2-[(1R)-5-(6-methylpyrimidin-4-yl)-2,3-dihydro-1H-inden-1-yl]-2,7-diazaspiro[3.5]nonan-7-yl]ethanone(Non-covalent)

1KQ.3: 19 residues within 4Å: Chain A: C.61, L.64, D.65, R.68, G.78, L.81, C.82, F.85, Q.86, S.89, T.93, F.340, C.343, W.344, F.347, S.376, F.377, F.380, S.383 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:D.65, A:R.68, A:L.81, A:F.85, A:F.340, A:F.347 Salt bridges: A:D.65 pi-Stacking: A:W.344 1KQ.8: 20 residues within 4Å: Chain B: C.61, L.64, D.65, R.68, Q.71, W.75, G.78, L.81, C.82, F.85, Q.86, S.89, T.93, C.164, F.340, W.344, F.347, S.376, F.377, F.380 9 PLIP interactions: 9 interactions with chain B Hydrophobic interactions: B:L.64, B:W.75, B:L.81, B:F.85, B:T.93, B:F.340, B:F.347 Salt bridges: B:D.65 pi-Stacking: B:W.344

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Qin, J. et al., Molecular mechanism of agonism and inverse agonism in ghrelin receptor. Nat Commun (2022)

Release Date

2022-01-19

Peptides

Growth hormone secretagogue receptor type 1,Soluble cytochrome b562: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Membrane

We predict this structure to be a membrane protein.
Show / Hide

Growth hormone secretagogue receptor type 1,Soluble cytochrome b562